Mirtazapine Zentiva

Mirtazapine, the active ingredient in Mirtazapine Zentiva, is a NaSSA (noradrenergic and specific serotonergic antidepressant) presented as an oral tablet for oral use. It is prescribed for the treatment of major depressive disorder in adult patients through modulation of neurotransmitters.

GNH USA supplies Mirtazapine Zentiva as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, with a focus on quality assurance and regulatory compliance. Our distribution network ensures timely delivery across multiple continents and adherence to local import requirements.

Mirtazapine acts on the noradrenergic and serotonergic pathways to treat depressive disorders. - Major depressive disorder: alleviation of depressive symptoms in adult patients. - Depressive symptoms with comorbid anxiety: improvement of mood and reduction of anxiety features. - Sleep disturbances associated with depression: enhancement of sleep quality and reduction of insomnia.

Mirtazapine may cause a range of adverse reactions, varying from mild to serious. Common Side Effects: - Sedation: drowsiness or feeling unusually sleepy. - Increased appetite: heightened desire for food, especially carbohydrates. - Dry mouth: reduced salivation causing oral discomfort. Serious or Rare Side Effects: - Agranulocytosis: severe reduction of white blood cells requiring immediate medical attention. - Hepatic dysfunction: signs of liver injury such as jaundice or elevated enzymes. - Stevens‑Johnson syndrome: severe skin reaction with blistering and mucosal involvement.

When prescribing mirtazapine, clinicians should consider several safety precautions to minimize risk. - Monitor weight: patients may experience significant weight gain and should have regular weight checks. - Assess for suicidal ideation: especially during early treatment or dose changes. - Evaluate hepatic function: use caution in patients with liver impairment. - Avoid abrupt discontinuation: tapering may be needed to reduce withdrawal symptoms. - Caution in elderly: increased sensitivity to sedation and falls. - Store at ambient temperature: keep below 25°C in the original packaging, protected from moisture.

Mirtazapine can interact with other medicines, affecting its efficacy or safety. Major Interactions (Avoid): - MAO inhibitors: concurrent use can cause hypertensive crisis or serotonin syndrome. - Strong CYP1A2 inhibitors: may increase mirtazapine plasma levels, raising risk of toxicity. Moderate Interactions (Monitor Closely): - CNS depressants (e.g., benzodiazepines, alcohol): additive sedation. - Anticoagulants (e.g., warfarin): potential increase in bleeding risk. - Serotonergic agents (e.g., SSRIs, SNRIs): may elevate risk of serotonin syndrome.